Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases.

See DNDi‘s vision & mission and objectives.


DNDi is working on the following diseases:

Malaria Icon

Malaria
Portfolio handed over in 2015


GARDP IconIn 2016, in collaboration with the World Health Organization, DNDi launched the Global Antibiotic Research & Development Partnership (GARDP), a not-for-profit research and development organization to develop new antibiotic treatments addressing antimicrobial resistance and to promote their responsible use for optimal conservation, while ensuring equitable access for all.